Myasthenia gravis, an autoimmune disorder, results from the production of antibodies against acetylcholine receptors in...
Free
70.2K
Verified Solution
Link Copied!
Question
Medical Sciences
Myasthenia gravis, an autoimmune disorder, results from the production of antibodies against acetylcholine receptors in the body.Â
a. Could repeated injections of human acetylcholine receptor into an animal model produce clinical symptoms in that animal?Â
b. Does the disease only impact the neuromuscular junction?Â
c. Does the disease directly affect the release of neurotransmitter?
Answer & Explanation
Solved by verified expert
3.8 Ratings (587 Votes)
Myasthenia gravis disease arise from the production of
autoantibodies against acetylcholine receptors on skeletal muscle.
It is an chronic autoimmune neuromuscular disease characterized by
varying degree of weakness of skeletal muscle. It is caused by
defect in transmission of nerve impulse to muscles.
B.in myasthenia gravis antibodies block alter or destroy the
receptors for acetylcholine at Nuerotranmitter junction which
prevents muscle contraction .so Neuromuscular junctions are
affected only .
C.no myasthenia gravis disease doesnot directly affect release
of neurotransmitters instead the antibodies block the receptors for
acetylcholine at Nueromuscular junction.
Get Answers to Unlimited Questions
Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!
Membership Benefits:
Unlimited Question Access with detailed Answers
Zin AI - 3 Million Words
10 Dall-E 3 Images
20 Plot Generations
Conversation with Dialogue Memory
No Ads, Ever!
Access to Our Best AI Platform: Zin AI - Your personal assistant for all your inquiries!
